Previously writing on medical monitoring technology group Deltex Medical (DEMG), in July with the shares down to 1.10p I wrote emphasises higher revenue, but how’s the balance sheet?!. What of now results for the first half of 2022 and a 0.925p share price?
Medical monitoring technology group Deltex Medical (DEMG) has issued a half-year trading update including “revenues for the six months ended 30 June 2022 increased approximately 9%” and that it expects to drive higher revenues. So what of a share price currently down more than 4% to 1.10p in response?
Medical technology group Deltex (DEMG) has updated on its AGM that “there are encouraging signs that the group's revenues in the UK and USA are beginning to recover”. So what of a current 1.10p share price?...
Previously writing on Deltex Medical Group (DEMG), in February I concluded cash flow concerns meant, at least ahead of further results insight, I continued to avoid. It has now announced 2021 results.
Deltex Medical (DEMG) has announced that “the board has concluded that it is now appropriate to raise a total of approximately £1.4 million… at a price of 1.25 pence per Deltex Medical ordinary share… (i) to launch, market and commercialise the next generation TrueVue monitor as well as a new non-invasive Doppler probe; (ii) to provide the financial resources required to support the substantial grant funding already won… and (iii) for the general working capital needs of the business”. Really?...
Haemodynamic monitoring technologies group Deltex Medical (DEMG) has made a “Pre-close statement”, noting that despite pandemic disruptions for the whole of the year this time, “revenues for the year ended 31 December 2021 were £2.3 million (2020: £2.4 million)” and belief that the backlog in elective surgery “represents a key opportunity for Deltex Medical as the group's TrueVue Doppler technology can be used to help minimise patient length of stay (and associated costs) following elective surgery and hence increase capacity for hospitals”. With also a ‘next generation’ TrueVue monitor due for release later this year, why a current share price fall to 1.25p?...
